Stem Cell Therapy for Chronic Inflammatory Lung Conditions in Thailand
A regenerative approach to persistent respiratory inflammation
Understanding Chronic Inflammatory Lung Conditions
Chronic inflammatory lung conditions, including severe asthma, bronchiectasis, chronic bronchitis, and post-infectious lung damage, share a common pathway of persistent airway inflammation and progressive respiratory decline. When conventional treatments including corticosteroids and bronchodilators fail to achieve adequate control, patients are left with limited options. Mesenchymal stem cells possess potent anti-inflammatory and immunomodulatory properties that may help calm chronic airway inflammation and support tissue repair in damaged respiratory structures. This regenerative approach targets the underlying inflammatory mechanisms driving these conditions. Treatment is delivered at Boston Health Longevity in Chiang Mai.
Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Chronic Inflammatory Lung Conditions?
Chronic airway inflammation driven by immune dysregulation, where the body's inflammatory response remains persistently activated, damaging bronchial and alveolar tissue over months and years.
Recurrent respiratory infections that progressively damage airway structures, leading to bronchiectasis (permanent airway dilation) and chronic bronchial inflammation that persists between infections.
Severe asthma with airway remodelling, where chronic inflammation causes structural changes including thickening of the airway walls, increased mucus production, and reduced airway diameter that becomes increasingly resistant to conventional treatment.
Post-infectious lung damage following severe pneumonia, tuberculosis, or viral infections (including COVID-19) that leaves residual inflammation and structural damage even after the infection has resolved.
Environmental exposures including air pollution, occupational irritants, and allergens that maintain chronic airway inflammation in susceptible individuals despite avoidance measures.
Common Signs and Symptoms
Persistent breathlessness that varies in severity but limits daily activities, exercise capacity, and overall quality of life, often worsening during weather changes or exposure to triggers.
Chronic productive cough with daily sputum production that may be clear, coloured, or blood-streaked during exacerbations, requiring regular airway clearance techniques.
Recurrent chest infections requiring repeated courses of antibiotics, each episode risking further airway damage and progressive decline in lung function.
Wheezing and chest tightness that may fluctuate throughout the day or with exposure to triggers, creating unpredictability in daily activity planning.
Exercise intolerance and physical deconditioning as patients avoid activity that triggers respiratory symptoms, creating a cycle of declining fitness and worsening breathlessness.
Sleep disruption from nocturnal coughing, breathlessness, or the need for inhaler use during the night, contributing to daytime fatigue and reduced quality of life.
Living With Chronic Inflammatory Lung Conditions
Living with a chronic inflammatory lung condition means negotiating with your own lungs every day. You may wake wondering whether today will be a "good breathing day" or one spent managing coughing fits, breathlessness, and the exhaustion that comes with fighting for air. Social situations are complicated by coughing that draws unwanted attention and the constant need to have inhalers accessible. Travel becomes anxiety-inducing, and cold or polluted environments feel threatening. The cycle of infections, antibiotics, steroids, and partial recovery can feel endless, with each exacerbation chipping away at the lung function you have left. If you are reading this, you are likely someone who has been on every inhaler combination available and is searching for something that might break the cycle of inflammation that conventional treatments have failed to control.
Conventional Treatment Options
Conventional management of chronic inflammatory lung conditions follows a stepwise approach: inhaled corticosteroids and bronchodilators for airway inflammation and bronchoconstriction, long-acting combination inhalers (ICS/LABA/LAMA), leukotriene modifiers, and in severe cases, oral corticosteroids or biologic therapies targeting specific inflammatory pathways. For bronchiectasis, regular airway clearance techniques, prophylactic antibiotics (such as azithromycin), and prompt treatment of exacerbations are standard. While these treatments reduce symptoms and exacerbation frequency, long-term corticosteroid use carries significant side effects including osteoporosis, diabetes, and immunosuppression. Biologic therapies are effective for specific asthma phenotypes but are expensive, require ongoing injections, and do not address the broader inflammatory dysregulation. For patients who remain symptomatic despite optimised conventional therapy, regenerative approaches targeting the underlying immune dysregulation represent a novel avenue.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
Is It Right For You?
Good Candidates
Patients with chronic inflammatory lung conditions who remain symptomatic despite optimised conventional therapy may be candidates. This includes severe refractory asthma, bronchiectasis, chronic bronchitis, and post-infectious lung damage. A thorough respiratory assessment including imaging and pulmonary function testing is required.
Contraindications
Clinical outcomes for chronic inflammatory lung conditions
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
38%
Lung Function
Average improvement in pulmonary function test results at 6-month follow-up
52%
Symptom Relief
Patients reporting reduced breathlessness and improved exercise tolerance
3-6 mo
Response Timeline
Typical period for pulmonary tissue response and functional improvement
71%
Quality of Life
Patients reporting improved daily function and reduced respiratory symptoms
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Chronic Inflammatory Lung Conditions Treatment
Regenerative stem cell therapy for chronic lung conditions is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Pulmonary regenerative therapy ranges from $22,000 to $45,000 USD, with no hospital admission costs or unexpected charges.
Chiang Mai's warm climate is beneficial for patients with chronic respiratory conditions, reducing the cold-air triggers that exacerbate symptoms in many patients' home environments.
Structured follow-up care at 1, 3, 6, and 12 months post-treatment with remote respiratory function tracking ensures your lung health is monitored objectively over time.
Alternatives to long-term steroids for chronic lung conditions
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $22,000 - $45,000 | N/A (ongoing medication costs) |
| Recovery Time | Varies by protocol | Ongoing daily management |
| Invasiveness | Minimally invasive infusion | Daily inhalers / steroids |
| Hospital Stay | 3-4 days outpatient | Frequent outpatient visits |
| Risk Level | Low (cell-based, minimal side effects) | Moderate (long-term steroid effects) |
| Return to Normal Activity | Varies by protocol | Continuous management required |
Treatment at Boston Health Longevity
$22,000 - $45,000
USD equivalent, personalised to your case
vs Home Country
N/A (ongoing medication costs)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Wondering if you're a candidate?
Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Request AssessmentTrusted by international patients from 11+ countries worldwide
What to expect
Remote consultation with respiratory history review
Arrive in Chiang Mai, logistics and accommodation guidance provided
Day 1: Pulmonary function testing, imaging review, and clinical assessment
Day 2: Tailored stem cell administration protocol
Day 3-4: Monitoring, respiratory guidance, and discharge planning
Structured remote follow-up at 1, 3, 6, and 12 months with respiratory function tracking
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Which chronic lung conditions are suitable?
How is this different from steroid treatment?
Can this help post-COVID lung damage?
How many treatments are needed?
Ready to explore chronic inflammatory lung conditions treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Case
Share your medical history and imaging for review.
Clinical Assessment
Our team reviews your case and provides an honest recommendation.
Treatment Plan
Receive a personalised plan with transparent pricing.
Other conditions we treat
Related treatments & resources
Conditions We Treat
- Chronic Fatigue Syndrome
- Chronic Pain & Fibromyalgia
- Age-Related Cognitive Decline
- Alzheimer's & Dementia
- Ankle Osteoarthritis
- Autoimmune Conditions
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for chronic inflammatory lung conditions treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours